Skip to main content
Clinical Trials/DRKS00024351
DRKS00024351
Completed
Not Applicable

Evaluation of a specialized inpatient treatment of the early intervention and therapy centre FRITZ for young people with early-phase psychosis: Improving attitudes towards medication and patient satisfaction.

Klinik für Psychiatrie, Psychotherapie und Psychosomatik Vivantes Klinikum Am Urban und Klinikum im Friedrichshain Akademische Lehrkrankenhäuser Charité-Universitätsmedizin Berlin0 sites98 target enrollmentFebruary 11, 2021
ConditionsPsychosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Psychosis
Sponsor
Klinik für Psychiatrie, Psychotherapie und Psychosomatik Vivantes Klinikum Am Urban und Klinikum im Friedrichshain Akademische Lehrkrankenhäuser Charité-Universitätsmedizin Berlin
Enrollment
98
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 11, 2021
End Date
May 21, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik für Psychiatrie, Psychotherapie und Psychosomatik Vivantes Klinikum Am Urban und Klinikum im Friedrichshain Akademische Lehrkrankenhäuser Charité-Universitätsmedizin Berlin

Eligibility Criteria

Inclusion Criteria

  • 1\) a diagnosis of a psychotic disorder according to the tenth revision of the International Classification of Mental and Behavioural Disorders (ICD\-10;World Health Organization; including diagnoses of substance\-induced psychosis F1x.5, schizophrenia\-spectrum disorders F2x, mania with psychotic symptoms F30\.2, bipolar affective disorder with psychotic symptoms F31\.2/F31\.5, and severe depression with psychotic symptoms F32\.3/F33\.3\)
  • 2\) onset of the first psychotic episode did not exceed five years or presentation to mental health services did not occur more than five years ago
  • 3\) willingness to participate in the therapy program at FRITZ
  • 4\) sufficient intellectual abilities and proficiency in German to complete study procedures
  • 5\) Able to give informed consent.

Exclusion Criteria

  • Patient refuses to participate the Treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials